- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged a Daily Mail article promoted Shingrix (POM) to the public. PMCPA found no evidence the article resulted from GSK’s business…
PMCPA found Valneva’s HCP “Valneva in Partnership” site promoted its Japanese encephalitis vaccine (Ixiaro) despite no product name, and breached Clause 12.1…
A UK physician alleged a shingles TV ad and linked disease-awareness site indirectly promoted GSK’s Shingrix. PMCPA Panel found the content balanced…
A complaint alleged an Astellas LinkedIn post was promotional and not properly approved (no job bag/date; liked/shared by sales/marketing). The PMCPA ruled…
Complaint alleged Wegovy was promoted at a Scotland meeting to NI HCPs before NI marketing authorisation. Panel found Wegovy had MA in…
Complaint said a Trixeo HCP eligibility checklist omitted SmPC counselling/stop-treatment text for acute narrow-angle glaucoma. Panel found breaches, but Appeal Board overturned:…
PMCPA ruled GSK’s Zejula “PRIMA AE management” webpage misleading for implying AEs could be managed by dose interruption/modification without highlighting when SmPC…
Anonymous ex-employee alleged Moderna misused preprint vaccine effectiveness data, cherry-picked graphs and sought UK contract advantage via JCVI presentations. Panel found no…
A UK-based GSK Global employee ‘celebrated’ a third-party LinkedIn post about promising niraparib results in glioblastoma. PMCPA found promotion to the public…
A pharmacist complained about a rep’s claim that NICE said infliximab SC fell under infliximab IV TAG due to cost neutrality. Panel…
Complaint alleged Jemperli HCP webpages weren’t properly certified for mobile due to layout/navigation differences and that a “manageable safety profile” claim was…
Complaint alleged a Trelegy Ellipta rotating banner promoted an unlicensed switch from three inhalers (incl. SABA). PMCPA Panel found no breach of…
A hospital pharmacist complained about a Pfizer-authorised letter asking hospitals to add Ecalta and Celsentri to electronic prescribing/dispensing systems. The Panel ruled…
A PCT pharmacist alleged a Clenil cost-comparison chart was misleading because it omitted 200mcg data. The Panel found the Scottish Drug Tariff…
A letter about the UK HPV vaccine tender was ruled promotional for Gardasil, lacked prescribing information and adverse event reporting guidance, and…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.